T1	Outcomes 1206 1233	CAF-specific pSMAD2 levels,
T2	Outcomes 1300 1331	TGF-Î² signalling in fibroblasts
T3	Outcomes 1670 1721	cell growth, proliferation and clonogenic survival.
T4	Outcomes 1796 1824	tumour weight and proportion